{
    "id": 17162,
    "cites": 33,
    "cited_by": 0,
    "reference": [
        "Armantier,  Olivier  and  Soiliou  Namoro  (2006).  Prescription  Drug  Advertising  and Patient Compliance: A Physician Agency Approach. Advances in Economic Analysis & Policy 6 (1) Article 5. Berkeley Electronic Press.",
        "Berndt, Ernst R., The United States Experience with DirecttoConsumer Advertising of Prescription Drugs: What Have We Learned? In Frank A. Sloan and CheeRuey Hsieh, eds.,  Promoting  and  Coping  with  Pharmaceutical  Innovation:  An  International Perspective, Cambridge University Press, 2006.",
        "Bradford, W David, Andrew N Kleit, Paul J Nietert, and Steven Ornstein (2010). The Effect  of  DirecttoConsumer  Television  Advertising  on  the  Timing  of  Treatment. Economic Inquiry 48 (2): 306  317.",
        "Brekke,  Kurt  R  and  Michael  Kuhn  (2005).  Direct  to  Consumer  Advertising  in Pharmaceutical Markets. Journal of Health Economics 25 (1): 102  130.",
        "Brick,  Ivan  E.  and  Harsharanjeet  S.  Jagpal  Monopoly  PriceAdvertising  Decision Making under Uncertainty Journal of Industrial Economics, Vol. 29, No. 3 (Mar., 1981), pp. 279285.",
        "Calfee, John E., Winston, Clifford, and Stempski, Randolph. (2002). DirecttoConsumer Advertising and the Demand for CholesterolReducing Drugs. The Journal of Law and Economics, 45: 673690.",
        "Chan,  Tat,  Chakravarthi  Narasimhan  and  Ying  Xie  (2007),  Impact  of  Treatment Effectiveness  and  Side  effects  on  Prescription  Decisions:  The  Role  of  Patient Heterogeneity and Learning, working paper, Washington University in St. Louis.",
        "Ching, Andrew and Masakazu Ishihara (2010), The Effects of Detailing on Prescribing Decisions under Quality Uncertainty, Quantitative Marketing and Economics, vol.8(2), pp.123165.",
        "Crawford,  Gregrory  S  and  Matthew  Shum  (2005).  Uncertainty  and  Learning  in Pharmaceutical Demand. Econometrica 73 (4): 1137  1173.",
        "Danzon,  Patricia  Regulation  of  the  BioPharmaceutical  Industry  in  Encyclopedia  of Law and Economics. Edward Elgar. 2011 David, Guy, Sara Markowitz, and Seth RichardsShubik, The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation. American Economic Journal  Economic Policy 2(4), November 2010, pp 125.",
        "Dehez,  Pierre  and  Alex  Jacquemin  A  Note  on  Advertising  Policy  under  Uncertainty and Dynamic Conditions Journal of Industrial Economics, Vol. 24, No. 1 (Sep., 1975), pp. 7378.",
        "DiMasi,  J.A.  and  Paquette,  C.  The  Economics  of  Followon  Drug  Research  and Development:  Trends  in  Entry  Rates  and  the  Timing  of  Development. Pharmacoeconomics, 22 no.s2 (2004): p. 114.",
        "Dorfman,  Robert  and  Peter  O.  Steiner  Optimal  Advertising  and  Optimal  Quality American Economic Review, Vol. 44, No. 5 (Dec., 1954), pp. 826836.",
        "Horowitz, Ira A Note on Advertising and Uncertainty Journal of Industrial Economics, Vol. 18, No. 2 (Apr., 1970), pp. 151160.",
        "Hurwitz, Mark A. and Richard E. Caves (1988), Persuasion or Information? Promotion and  the  Shares  of  Brand  Name  and  Generic  Pharmaceuticals,  Journal  of  Law  and Economics, vol.31, pp.299320.",
        "Institute of Medicine. The Future Of Drug Safety: Promoting And Protecting The Health Of  The  Public.  Alina  Baciu,  Kathleen  Stratton,  Sheila  P.  Burke,  Editors.  The  National Academies Press: Washington, DC. 2007.",
        "Iizuka, Toshiaki (2004). What Explains the Use of DirecttoConsumer Advertising of Prescription Drugs? Journal of Industrial Economics 52 (3): 349  379.",
        "Iizuka, Toshiaki, and Jin, Ginger Z. (2005). The Effect of Prescription Drug Advertising on Doctor Visits Journal of Economics & Management Strategy 14 (3): 701  727.",
        "Jena,  Anupam  B.,  John  E.  Calfee,  Edward  C.  Mansley,  and  Tomas  J.  Philipson  (2009) `MeToo' Innovation in Pharmaceutical Markets Forum for Health Economics & Policy: Vol. 12(1): (Frontiers in Health Policy Research), Article 5.",
        "Kenkel,  Donald  and  Alan  Mathios  Promotion  to  Physicians  and  Consumers.  In Handbook on the Economics of the Biopharmaceutical Industry, Patricia Danzon and Sean Nicholson, Editors. Oxford University Press, 2011.",
        "Kessler, D.A., Rose, J.L., Temple, R.J., Schapiro, R., and Griffin, J.P. (1994) Therapeutic Class  WarsDrug  Promotion  in  a  Competitive  Marketplace.  New  England  Journal  of Medicine, 331 no. 20: pp. 13501353.",
        "Kim, Minki Physician Learning and New Drug Diffusion Working paper  University of Chicago, 2011.",
        "Lee, T.H. (2004) MeToo ProductsFriend or Foe? New England Journal of Medicine, 350 no. 3: p. 2112.",
        "Leffler, Keith (1981), Persuasion or Information? The Economics of Prescription Drug Advertising,Journal of Law and Economics, vol.24, pp.4574.",
        "Linnosmaa,  Ismo  Erkii  (2008).  Advertising,  FreeRiding,  and  Price  Differences  in  the Market for Prescription Drugs. B.E. Journal of Economic Analysis and Policy 8(2): Article 8.",
        "Mayo Foundation for Medical Education and Research (MFMER) Erectile dysfunction: Viagra and other oral medications. 2008.",
        "Meyerhofer, Chad D and Samuel H Zuvekas (2008). The Shape of Demand: What Does It Tell Us about DirecttoConsumer Marketing of AntiDepressants? B.E. Journal of Economic Analysis and Policy: Advances. 8 (2).",
        "Narayanan, Sridhar and Puneet Manchanda (2009), Heterogeneous Learning and the Targeting  of  Marketing  Communication  for  New  Products,  Marketing  Science,  vol. 28(3), pp.424441.",
        "Newey,  Whitney  K;  West,  Kenneth  D  (1987).  A  Simple,  Positive  Semidefinite, Heteroskedasticity and Autocorrelation Consistent Covariance Matrix. Econometrica 55 (3): 703708.",
        "Rosenthal,  Meredith  B.,  Ernst  R.  Berndt,  Julie  M.  Donohue,  Arnold  M.  Epstein,  and Richard  G.  Frank  (2003)  Demand  Effects  of  Recent  Changes  in  Prescription  Drug Promotion,  Forum  for  Health  Economics  &  Policy:  Vol.  6:  (Frontiers  in  Health  Policy Research), Article 2.",
        "Scherer, F.M., 2000. The pharmaceutical industry. In: Newhouse, J.P. (Ed.), Handbook of Health Economics, vol. 1. Elsevier, Amsterdam, Chapter 25, pp. 12971336.",
        "Towse,  Adrian  and  Patricia  Danzon  Regulation  of  the  Pharmaceutical  Industry.  In Handbook on Regulation, ed. Martin Cave. Oxford University Press. 2010.",
        "Waldman,  Don  E.  and  Elizabeth  J.  Jensen  (2007)  Industrial  Organization:  Theory  and Practice, 3rd edition, Prentice Hall"
    ]
}